Skip to main content

Want a detailed portfolio tracker?

NovaBridge Biosciences. (NBP) P/E (2020 - 2026)

NovaBridge Biosciences. (NBP) P/E from Dec 31, 2020 to Jun 3, 2026. The TTM NovaBridge Biosciences. (NBP) P/E is -11.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NovaBridge Biosciences. (NBP)

YearP/EChange
2026-11.18-56.03%
2025-25.43+12.87%
2024-22.53+5092.92%
2023-0.43-52.35%
2022-0.91-91.18%
2021-10.32-122.03%
202046.86N/A

Comparison NovaBridge Biosciences. (NBP) P/E with competitors

NovaBridge Biosciences. (NBP) P/E is -11.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.91%
ENLVEnlivex Therapeutics Ltd0.15-101.34%
FGENFibroGen Inc0.24-102.15%
TRAWTraws Pharma Inc0.47-104.23%
FBIOFortress Biotech Inc0.71-106.31%
CHRSCoherus Biosciences Inc0.98-108.75%
ORMPOramed Pharmaceuticals Inc1.47-113.18%
AGENAgenus Inc2.05-118.32%
VIVSVivoSim Labs Inc2.54-122.68%
INVAInnoviva Inc3.19-128.51%
CRMDCorMedix Inc3.65-132.60%
ABEOAbeona Therapeutics Inc4.20-137.60%
VXRTVaxart Inc4.26-138.11%
CVACCureVac N.V.4.45-139.76%
SRPTSarepta Therapeutics Inc4.62-141.35%
GLPGGalapagos NV4.86-143.45%
RIGLRigel Pharmaceuticals4.92-143.99%
ZVRAZevra Therapeutics Inc4.97-144.48%
ABUSArbutus Biopharma Corp5.69-150.92%
CGENCompugen Ltd7.38-166.03%
AUPHAurinia Pharmaceuticals Inc9.25-182.73%
ACADAcadia Pharmaceuticals Inc9.59-185.74%
OMEROmeros Corporation9.88-188.39%
PLXProtalix BioTherapeutics Inc9.91-188.62%
SPROSpero Therapeutics Inc10.73-196.00%
ADMAAdma Biologics Inc11.33-201.33%
SVASinovac Biotech Ltd11.44-202.27%
TBPHTheravance Biopharma Inc11.78-205.32%
HRMYHarmony Biosciences Holdings Inc12.18-208.93%
TGTXTG Therapeutics Inc13.18-217.86%
INCYIncyte Corp13.38-219.67%
SABSSAB Biotherapeutics Inc14.06-225.72%
XOMAXOMA Corp14.95-233.65%
REGNRegeneron Pharmaceuticals Inc14.98-233.97%
PBYIPuma Biotechnology Inc15.05-234.59%
EXELExelixis Inc15.79-241.25%
NAGENiagen Bioscience Inc16.35-246.26%
CPRXCatalyst Pharmaceuticals Inc17.34-255.11%
MDXGMimedx Group Inc17.38-255.39%
ARGXArgen X SE23.07-306.33%
HALOHalozyme Therapeutics Inc23.20-307.48%
XOMAOXOMA Corp25.34-326.66%
VRTXVertex Pharmaceuticals Inc25.66-329.44%
XOMAPXOMA Corp25.67-329.57%
CTMXCytomX Therapeutics Inc25.70-329.81%
ASNDAscendis Pharma A/S26.35-335.68%
RPRXRoyalty Pharma plc - Class A27.50-345.89%
SLNOSoleno Therapeutics Inc29.02-359.48%
LGNDLigand Pharmaceuticals Inc - Class B30.19-369.96%
BMRNBiomarin Pharmaceutical Inc37.51-435.42%
APLSApellis Pharmaceuticals Inc39.02-448.96%
KRYSKrystal Biotech Inc39.70-455.01%
GMABGenmab40.20-459.54%
ONCBeiGene Ltd67.03-699.42%
TECHBio-Techne Corp68.59-713.44%
VCELVericel Corp80.63-821.06%
PHARPharming Group N.V.87.74-884.65%
ALNYAlnylam Pharmaceuticals Inc124.93-1217.27%
TLXTelix Pharmaceuticals Ltd139.89-1351.03%
CORTCorcept Therapeutics Inc158.39-1516.46%